Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study

NCT03128762 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03128762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03128762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Innate Lymphoid Cell Type 2 (ILC2) Levels and Asthma: a Case-control Study
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
June 25, 2014
Completion date
June 23, 2015
Enrollment
36 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma